Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 77

1.

The structure of the influenza A virus genome.

Dadonaite B, Gilbertson B, Knight ML, Trifkovic S, Rockman S, Laederach A, Brown LE, Fodor E, Bauer DLV.

Nat Microbiol. 2019 Jul 22. doi: 10.1038/s41564-019-0513-7. [Epub ahead of print]

PMID:
31332385
2.

Downregulation of MHC Class I Expression by Influenza A and B Viruses.

Koutsakos M, McWilliam HEG, Aktepe TE, Fritzlar S, Illing PT, Mifsud NA, Purcell AW, Rockman S, Reading PC, Vivian JP, Rossjohn J, Brooks AG, Mackenzie JM, Mintern JD, Villadangos JA, Nguyen THO, Kedzierska K.

Front Immunol. 2019 May 29;10:1158. doi: 10.3389/fimmu.2019.01158. eCollection 2019.

3.

Nitrogen deprivation in Fusarium oxysporum promotes mycotoxin production via intermediates in the Krebs cycle and unreported methylmalonyl-CoA mutase activity.

Karpe AV, Dunn MS, Taylor MC, Nguyen T, Ong C, Karla T, Rockman S, Beale DJ.

Metabolomics. 2018 Dec 11;14(12):160. doi: 10.1007/s11306-018-1459-0.

PMID:
30830469
4.

Human CD8+ T cell cross-reactivity across influenza A, B and C viruses.

Koutsakos M, Illing PT, Nguyen THO, Mifsud NA, Crawford JC, Rizzetto S, Eltahla AA, Clemens EB, Sant S, Chua BY, Wong CY, Allen EK, Teng D, Dash P, Boyd DF, Grzelak L, Zeng W, Hurt AC, Barr I, Rockman S, Jackson DC, Kotsimbos TC, Cheng AC, Richards M, Westall GP, Loudovaris T, Mannering SI, Elliott M, Tangye SG, Wakim LM, Rossjohn J, Vijaykrishna D, Luciani F, Thomas PG, Gras S, Purcell AW, Kedzierska K.

Nat Immunol. 2019 May;20(5):613-625. doi: 10.1038/s41590-019-0320-6. Epub 2019 Feb 18.

PMID:
30778243
5.

8-channel WDM silicon photonics transceiver with SOA and semiconductor mode-locked laser.

Moscoso-Mártir A, Tabatabaei-Mashayekh A, Müller J, Nojić J, Setter R, Nielsen M, Sandomirsky A, Rockman S, Mentovich E, Merget F, Garreau A, Lelarge F, Witzens J.

Opt Express. 2018 Sep 17;26(19):25446-25459. doi: 10.1364/OE.26.025446.

PMID:
30469646
6.

Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection.

Vanderven HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, Jegaskanda S, Wheatley AK, Wentworth D, Wines BD, Hogarth PM, Rockman S, Kent SJ; INSIGHT FLU005 Pilot Study Writing Group.

J Infect Dis. 2018 Sep 22;218(9):1383-1393. doi: 10.1093/infdis/jiy328.

PMID:
29860297
7.

Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).

Fernando GJP, Hickling J, Jayashi Flores CM, Griffin P, Anderson CD, Skinner SR, Davies C, Witham K, Pryor M, Bodle J, Rockman S, Frazer IH, Forster AH.

Vaccine. 2018 Jun 18;36(26):3779-3788. doi: 10.1016/j.vaccine.2018.05.053. Epub 2018 May 17.

8.

Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity.

Koutsakos M, Wheatley AK, Loh L, Clemens EB, Sant S, Nüssing S, Fox A, Chung AW, Laurie KL, Hurt AC, Rockman S, Lappas M, Loudovaris T, Mannering SI, Westall GP, Elliot M, Tangye SG, Wakim LM, Kent SJ, Nguyen THO, Kedzierska K.

Sci Transl Med. 2018 Feb 14;10(428). pii: eaan8405. doi: 10.1126/scitranslmed.aan8405.

PMID:
29444980
9.

Antibody-Dependent Cellular Cytotoxicity Responses to Seasonal Influenza Vaccination in Older Adults.

Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ.

J Infect Dis. 2017 Dec 27;217(1):12-23. doi: 10.1093/infdis/jix554.

PMID:
29106590
10.

Silicon Photonics Transmitter with SOA and Semiconductor Mode-Locked Laser.

Moscoso-Mártir A, Müller J, Hauck J, Chimot N, Setter R, Badihi A, Rasmussen DE, Garreau A, Nielsen M, Islamova E, Romero-García S, Shen B, Sandomirsky A, Rockman S, Li C, Sharif Azadeh S, Lo GQ, Mentovich E, Merget F, Lelarge F, Witzens J.

Sci Rep. 2017 Oct 24;7(1):13857. doi: 10.1038/s41598-017-14347-3.

11.

Introduction.

Rockman S.

Technol Cult. 2017;58(2):487-505. doi: 10.1353/tech.2017.0044.

PMID:
28649116
12.

Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza Infection.

Rockman S, Lowther S, Camuglia S, Vandenberg K, Taylor S, Fabri L, Miescher S, Pearse M, Middleton D, Kent SJ, Maher D.

EBioMedicine. 2017 May;19:119-127. doi: 10.1016/j.ebiom.2017.04.010. Epub 2017 Apr 6.

13.

Efficacy of a trivalent influenza vaccine against seasonal strains and against 2009 pandemic H1N1: A randomized, placebo-controlled trial.

Mcbride WJH, Abhayaratna WP, Barr I, Booy R, Carapetis J, Carson S, De Looze F, Ellis-Pegler R, Heron L, Karrasch J, Marshall H, Mcvernon J, Nolan T, Rawlinson W, Reid J, Richmond P, Shakib S, Basser RL, Hartel GF, Lai MH, Rockman S, Greenberg ME.

Vaccine. 2016 Sep 22;34(41):4991-4997. doi: 10.1016/j.vaccine.2016.08.038. Epub 2016 Aug 29.

14.

Influenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene.

Gilbertson B, Zheng T, Gerber M, Printz-Schweigert A, Ong C, Marquet R, Isel C, Rockman S, Brown L.

Viruses. 2016 Aug 20;8(8). pii: E238. doi: 10.3390/v8080238.

15.

What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.

Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, Chen W, Wines B, Hogarth PM, Lambe T, Gilbert SC, Parsons MS, Kent SJ.

EBioMedicine. 2016 Jun;8:277-290. doi: 10.1016/j.ebiom.2016.04.029. Epub 2016 Apr 28.

16.

Influenza-Specific Antibody-Dependent Phagocytosis.

Ana-Sosa-Batiz F, Vanderven H, Jegaskanda S, Johnston A, Rockman S, Laurie K, Barr I, Reading P, Lichtfuss M, Kent SJ.

PLoS One. 2016 Apr 28;11(4):e0154461. doi: 10.1371/journal.pone.0154461. eCollection 2016.

17.

Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.

Carolan LA, Rockman S, Borg K, Guarnaccia T, Reading P, Mosse J, Kelso A, Barr I, Laurie KL.

J Virol. 2015 Dec 30;90(6):2838-48. doi: 10.1128/JVI.02797-15.

18.

Inactivated Influenza Vaccine That Provides Rapid, Innate-Immune-System-Mediated Protection and Subsequent Long-Term Adaptive Immunity.

Chua BY, Wong CY, Mifsud EJ, Edenborough KM, Sekiya T, Tan AC, Mercuri F, Rockman S, Chen W, Turner SJ, Doherty PC, Kelso A, Brown LE, Jackson DC.

MBio. 2015 Oct 27;6(6):e01024-15. doi: 10.1128/mBio.01024-15.

19.

Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.

Londrigan SL, Short KR, Ma J, Gillespie L, Rockman SP, Brooks AG, Reading PC.

J Virol. 2015 Dec;89(24):12319-29. doi: 10.1128/JVI.01455-15. Epub 2015 Sep 30.

20.

Cold adaptation generates mutations associated with the growth of influenza B vaccine viruses.

Kim H, Velkov T, Camuglia S, Rockman SP, Tannock GA.

Vaccine. 2015 Oct 26;33(43):5786-5793. doi: 10.1016/j.vaccine.2015.09.038. Epub 2015 Sep 25.

PMID:
26407922
21.

Investigation into alternative testing methodologies for characterization of influenza virus vaccine.

Tay T, Agius C, Hamilton R, Bodle J, Rockman S.

Hum Vaccin Immunother. 2015;11(7):1673-84. doi: 10.1080/21645515.2015.1034914.

22.

Molecular Characterisation of the Haemagglutinin Glycan-Binding Specificity of Egg-Adapted Vaccine Strains of the Pandemic 2009 H1N1 Swine Influenza A Virus.

Carbone V, Schneider EK, Rockman S, Baker M, Huang JX, Ong C, Cooper MA, Yuriev E, Li J, Velkov T.

Molecules. 2015 Jun 5;20(6):10415-34. doi: 10.3390/molecules200610415.

23.

Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere trivalent influenza vaccine is associated with adverse events.

Rockman S, Dyson A, Koernig S, Becher D, Ng M, Morelli AB, Barnden M, Tang ML, Pearse M, Maraskovsky E.

Vaccine. 2014 Jun 24;32(30):3861-8. doi: 10.1016/j.vaccine.2014.03.032.

24.

Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses.

Jegaskanda S, Vandenberg K, Laurie KL, Loh L, Kramski M, Winnall WR, Kedzierska K, Rockman S, Kent SJ.

J Infect Dis. 2014 Dec 1;210(11):1811-22. doi: 10.1093/infdis/jiu334. Epub 2014 Jun 10.

PMID:
24916185
25.

Influenza virus PB1 and neuraminidase gene segments can cosegregate during vaccine reassortment driven by interactions in the PB1 coding region.

Cobbin JC, Ong C, Verity E, Gilbertson BP, Rockman SP, Brown LE.

J Virol. 2014 Aug;88(16):8971-80. doi: 10.1128/JVI.01022-14. Epub 2014 May 28.

26.

TaqMan real time RT-PCR assays for detecting ferret innate and adaptive immune responses.

Carolan LA, Butler J, Rockman S, Guarnaccia T, Hurt AC, Reading P, Kelso A, Barr I, Laurie KL.

J Virol Methods. 2014 Sep 1;205:38-52. doi: 10.1016/j.jviromet.2014.04.014. Epub 2014 May 4.

27.

Role of viral RNA and lipid in the adverse events associated with the 2010 Southern Hemisphere trivalent influenza vaccine.

Rockman S, Becher D, Dyson A, Koernig S, Morelli AB, Barnden M, Camuglia S, Soupourmas P, Pearse M, Maraskovsky E.

Vaccine. 2014 Jun 24;32(30):3869-76. doi: 10.1016/j.vaccine.2014.03.035. Epub 2014 Mar 25.

28.

Cold adaptation improves the growth of seasonal influenza B vaccine viruses.

Kim H, Schoofs P, Anderson DA, Tannock GA, Rockman SP.

Vaccine. 2014 May 1;32(21):2474-9. doi: 10.1016/j.vaccine.2014.02.079. Epub 2014 Mar 12.

PMID:
24631096
29.

Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposure.

He J, Tsai LM, Leong YA, Hu X, Ma CS, Chevalier N, Sun X, Vandenberg K, Rockman S, Ding Y, Zhu L, Wei W, Wang C, Karnowski A, Belz GT, Ghali JR, Cook MC, Riminton DS, Veillette A, Schwartzberg PL, Mackay F, Brink R, Tangye SG, Vinuesa CG, Mackay CR, Li Z, Yu D.

Immunity. 2013 Oct 17;39(4):770-81. doi: 10.1016/j.immuni.2013.09.007.

30.

Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccination.

Sedgmen BJ, Papalia L, Wang L, Dyson AR, McCallum HA, Simson CM, Pearse MJ, Maraskovsky E, Hung D, Eomois PP, Hartel G, Barnden MJ, Rockman SP.

Clin Dev Immunol. 2013;2013:186420. doi: 10.1155/2013/186420. Epub 2013 Aug 26.

31.

Molecular characterization of the receptor binding structure-activity relationships of influenza B virus hemagglutinin.

Carbone V, Kim H, Huang JX, Baker MA, Ong C, Cooper MA, Li J, Rockman S, Velkov T.

Acta Virol. 2013;57(3):313-32.

PMID:
24020757
32.

The antigenic architecture of the hemagglutinin of influenza H5N1 viruses.

Velkov T, Ong C, Baker MA, Kim H, Li J, Nation RL, Huang JX, Cooper MA, Rockman S.

Mol Immunol. 2013 Dec;56(4):705-19. doi: 10.1016/j.molimm.2013.07.010. Epub 2013 Aug 7. Review.

PMID:
23933511
33.

Comparison of influenza virus replication fidelity in vitro using selection pressure with monoclonal antibodies.

Wong KK, Rockman S, Ong C, Bull R, Stelzer-Braid S, Rawlinson W.

J Med Virol. 2013 Jun;85(6):1090-4. doi: 10.1002/jmv.23532.

PMID:
23588737
34.

The source of the PB1 gene in influenza vaccine reassortants selectively alters the hemagglutinin content of the resulting seed virus.

Cobbin JC, Verity EE, Gilbertson BP, Rockman SP, Brown LE.

J Virol. 2013 May;87(10):5577-85. doi: 10.1128/JVI.02856-12. Epub 2013 Mar 6.

35.

Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine.

Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, Kachurina O, Klippel J, Bodle J, Pearse M, Middleton D.

J Virol. 2013 Mar;87(6):3053-61. doi: 10.1128/JVI.02434-12. Epub 2013 Jan 2.

36.

Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodies.

Rockman S, Camuglia S, Vandenberg K, Ong C, Baker MA, Nation RL, Li J, Velkov T.

Mol Immunol. 2013 Apr;53(4):435-42. doi: 10.1016/j.molimm.2012.10.001. Epub 2012 Nov 3.

PMID:
23127859
37.

Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza Vaccine.

Maraskovsky E, Rockman S, Dyson A, Koernig S, Becher D, Morelli AB, Barnden M, Camuglia S, Bodle J, Vandenberg K, Wang IM, Cristescu R, Loboda A, Citron M, Fontenot J, Hung D, Schoofs P, Pearse M.

Vaccine. 2012 Dec 7;30(51):7400-6. doi: 10.1016/j.vaccine.2012.09.083. Epub 2012 Oct 9.

PMID:
23063831
38.

Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusion.

Bodle J, Verity EE, Ong C, Vandenberg K, Shaw R, Barr IG, Rockman S.

Influenza Other Respir Viruses. 2013 Mar;7(2):191-200. doi: 10.1111/j.1750-2659.2012.00375.x. Epub 2012 May 15.

39.

Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines.

Rockman S, Middleton DJ, Pearse MJ, Barr IG, Lowther S, Brown LE.

Vaccine. 2012 May 21;30(24):3618-23. doi: 10.1016/j.vaccine.2012.03.043. Epub 2012 Mar 30.

PMID:
22464969
40.

Abortive replication of influenza virus in mouse dendritic cells.

Ioannidis LJ, Verity EE, Crawford S, Rockman SP, Brown LE.

J Virol. 2012 May;86(10):5922-5. doi: 10.1128/JVI.07060-11. Epub 2012 Mar 14.

41.

The use of hyperimmune serum for severe influenza infections*.

Rockman S, Maher D, Middleton D.

Crit Care Med. 2012 Mar;40(3):973-5. doi: 10.1097/CCM.0b013e318236f486.

PMID:
22001587
42.

Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA.

Verity EE, Camuglia S, Agius CT, Ong C, Shaw R, Barr I, Middleton D, Rockman S.

Influenza Other Respir Viruses. 2012 Mar;6(2):101-9. doi: 10.1111/j.1750-2659.2011.00273.x. Epub 2011 Jul 19.

43.

A gel-capture assay for characterizing the sialyl-glycan selectivity of influenza viruses.

Velkov T, Thompson PE, El-Kabbani O, Lindh F, Stambas J, Rockman S.

Acta Virol. 2011;55(2):131-7.

PMID:
21692561
44.

Correlation of polymerase replication fidelity with genetic evolution of influenza A/Fujian/411/02(H3N2) viruses.

Wong KK, Bull RA, Rockman S, Scott G, Stelzer-Braid S, Rawlinson W.

J Med Virol. 2011 Mar;83(3):510-6. doi: 10.1002/jmv.21991.

PMID:
21264873
45.

The development of vaccine viruses against pandemic A(H1N1) influenza.

Robertson JS, Nicolson C, Harvey R, Johnson R, Major D, Guilfoyle K, Roseby S, Newman R, Collin R, Wallis C, Engelhardt OG, Wood JM, Le J, Manojkumar R, Pokorny BA, Silverman J, Devis R, Bucher D, Verity E, Agius C, Camuglia S, Ong C, Rockman S, Curtis A, Schoofs P, Zoueva O, Xie H, Li X, Lin Z, Ye Z, Chen LM, O'Neill E, Balish A, Lipatov AS, Guo Z, Isakova I, Davis CT, Rivailler P, Gustin KM, Belser JA, Maines TR, Tumpey TM, Xu X, Katz JM, Klimov A, Cox NJ, Donis RO.

Vaccine. 2011 Feb 17;29(9):1836-43. doi: 10.1016/j.vaccine.2010.12.044. Epub 2011 Jan 1.

PMID:
21199698
46.

Pre-pandemic and pandemic influenza vaccines.

Rockman S, Brown L.

Hum Vaccin. 2010 Oct;6(10):792-801. Epub 2010 Oct 1. Review.

PMID:
20935469
47.

A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.

Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA.

J Infect Dis. 2010 Nov 1;202(9):1327-37. doi: 10.1086/656601.

PMID:
20874515
48.

A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody.

Pejoski D, Zeng W, Rockman S, Brown LE, Jackson DC.

Immunol Cell Biol. 2010 Jul;88(5):605-11. doi: 10.1038/icb.2010.15. Epub 2010 Feb 23.

PMID:
20177411
49.

Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization.

Middleton D, Rockman S, Pearse M, Barr I, Lowther S, Klippel J, Ryan D, Brown L.

J Virol. 2009 Aug;83(15):7770-8. doi: 10.1128/JVI.00241-09. Epub 2009 May 20.

50.

Molecular cloning and characterization of pig, cow and sheep MAdCAM-1 cDNA and the demonstration of cross-reactive epitopes amongst mammalian homologues.

Tachedjian M, Yu M, Lew AM, Rockman S, Boyle JS, Andrew ME, Wang L.

Tissue Antigens. 2006 May;67(5):419-26.

PMID:
16671951

Supplemental Content

Loading ...
Support Center